JAMA Oncology Author Interviews cover image

Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality

JAMA Oncology Author Interviews

00:00

Is There a Risk of Missing Something?

We cannot conclude exact why it is that we're seeing this effect. But of course, longer follow up time would be beneficial. There were differences in the patients who were on five alpharoductes inhibitors having higher rates of p s a check per year and biopses per year. And you can't tell from the data we have available which of these or both might be contribute.

Play episode from 08:09
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app